Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
2010 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients
2006
Can the Nephrologist Prevent Dialysis-Related Amyloidosis?
1991
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis
2007
Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus.
1997
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
Psoriasis
2009 Standout
Are joints affected by gout also affected by osteoarthritis?
2007
Pathogenesis and clinical features of psoriasis
2007 Standout
Treatment of Deep Cartilage Defects in the Knee with Autologous Chondrocyte Transplantation
1994 Standout
Accelerated Systemic Autoimmunity in the Absence of Somatic Hypermutation in 564Igi: A Mouse Model of Systemic Lupus with Knocked-In Heavy and Light Chain Genes
2017 StandoutNobel
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
2008 Standout
Pathogenesis and therapy of psoriasis
2007 StandoutNature
The bath ankylosing spondylitis radiology index (BASRI): A new, validated approach to disease assessment
1998
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Juvenile idiopathic arthritis
2007 Standout
Diagnosis and treatment of psoriatic arthritis
2004
The effect of resistance training during radiotherapy on spinal bone metastases in cancer patients – A randomized trial
2014
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept
2008
Is gout associated with reduced quality of life? A case-control study
2007
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
2005 Standout
Psoriasis
2021 Standout
Animal models of autoimmunity and their relevance to human diseases
2000 StandoutNobel
A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus
2001
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day in patients with gout
2008
Gout
2009 Standout
The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases
2013
Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus. Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity
1997
Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors
2005
National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening
2008
Clinical management of psoriatic arthritis
2018
Psoriasis
2015 Standout
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
1998 Standout
Psoriasis: emerging therapeutic strategies
2005
Antibodies to DNA
1998
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
2007 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review
2014
The Role of Knee Alignment in Disease Progression and Functional Decline in Knee Osteoarthritis
2001 Standout
Ankylosing spondylitis
2007 Standout
Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis
2012
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
2005
Gout
2016 Standout
Gout in the Elderly
1998
Economic Evaluation of a Community‐based Obesity Prevention Program in Children: The APPLE Project
2009
Managing comorbid disease in patients with psoriasis
2010
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Clinical Aspects of the Spondyloarthropathies
1998
Infections in Patients with Diabetes Mellitus
1999 Standout
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial
2005
Determinants of hyperkyphosis in patients with ankylosing spondylitis
2005
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction
2005
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study
2013 Standout
The outcome of ankylosing spondylitis: a study of 100 patients.
1997
Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
2008
Functional Specialization of Interleukin-17 Family Members
2011 Standout
Risk factors for gout and prevention: a systematic review of the literature
2011
Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system
2004
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
2009
10 Years of GWAS Discovery: Biology, Function, and Translation
2017 Standout
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
2019 Standout
Most tumour necrosis factor inhibitor trials in rheumatology are undeservedly called 'efficacy and safety' trials: a survey of power considerations
2008
Adalimumab reduces spinal symptoms in active ankylosing spondylitis: Clinical and magnetic resonance imaging results of a fifty‐two–week open‐label trial
2006
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
2005 Standout
Idiopathic pulmonary fibrosis
2011 Standout
Bone metastases from differentiated thyroid carcinoma
2008
The evaluation of psoriasis therapy with biologics leads to a revision of the current view of the pathogenesis of this disorder
2006
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
What is the most appropriate radiologic scoring method for ankylosing spondylitis?
2004
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
2013
Inflammasomes in health and disease
2012 StandoutNature
Lupus Glomerulonephritis Revisited 2004: Autoimmunity and End‐Organ Damage
2004
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Basic Calcium Phosphate Crystals Induce Monocyte/Macrophage IL-1β Secretion through the NLRP3 Inflammasome In Vitro
2011
Clinical Aspects of the Spondyloarthropathies
1998
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
DEEP SOFT-TISSUE INFECTIONS IN DIABETIC PATIENTS
1995
Immunology of Psoriasis
2014 Standout
Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors
1998
Interventions for preventing obesity in children
2019 Standout
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
2003 Standout
Pathogenesis of Gout
2005
Comparison of Survival Probabilities for Dialysis Patients vs Cadaveric Renal Transplant Recipients
1993 Standout
Gout
2021 Standout
Autoimmune Alterations Induced by the New Zealand BlackLbw2Locus in BWF1 Mice
2005
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Magnetic resonance imaging of knee hyaline cartilage and intraarticular pathology
1987
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of Joel Rubenstein being referenced
Gouty arthritis in nodal osteoarthritis.
1996
Construct validation of the Health Utilities Index and the Child Health Questionnaire in children undergoing cancer chemotherapy
2003
Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus.
1996
Correlation of Computed Tomography Imaging Features With Pain Response in Patients With Spine Metastases After Radiation Therapy
2010
Hydroxyapatite pseudopodagra. A syndrome of young women
1989
Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression
2004
Computed tomography (CT) evaluation of breast cancer patients with osteolytic bone metastases undergoing palliative radiotherapy—a feasibility study
2004
Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.
2006
Pyomyositis: early detection and treatment.
1993
Erosive azotemic osteoarthropathy
1984
MR Imaging of the Normal Knee
1984
The natural disease course of ankylosing spondylitis
1983